Kaplan FS - Search Results

1

ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant.

Haupt J, Deichsel A, Stange K, Ast C, Bocciardi R, Ravazzolo R, Di Rocco M, Ferrari P, Landi A, Kaplan FS, Shore EM, Reissner C, Seemann P. Haupt J, et al. Among authors: kaplan fs. Hum Mol Genet. 2014 Oct 15;23(20):5364-77. doi: 10.1093/hmg/ddu255. Epub 2014 May 22. Hum Mol Genet. 2014. PMID: 24852373 Free PMC article.

2

Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva.

Kaplan F, Sawyer J, Connors S, Keough K, Shore E, Gannon F, Glaser D, Rocke D, Zasloff M, Folkman J. Kaplan F, et al. Clin Orthop Relat Res. 1998 Jan;(346):59-65. Clin Orthop Relat Res. 1998. PMID: 9577411

3

Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.

Shore EM, Ahn J, Jan de Beur S, Li M, Xu M, Gardner RJ, Zasloff MA, Whyte MP, Levine MA, Kaplan FS. Shore EM, et al. Among authors: kaplan fs. N Engl J Med. 2002 Jan 10;346(2):99-106. doi: 10.1056/NEJMoa011262. N Engl J Med. 2002. PMID: 11784876 Free article.

4

Reported noggin mutations are PCR errors.

Xu MQ, Shore EM, Kaplan FS. Xu MQ, et al. Among authors: kaplan fs. Am J Med Genet. 2002 Apr 22;109(2):161; author reply 163-4. doi: 10.1002/ajmg.10288. Am J Med Genet. 2002. PMID: 11977168 No abstract available.

5

Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.

Ahn J, Feldman G, Terry L, Shore EM, Kaplan FS. Ahn J, et al. Among authors: kaplan fs. Clin Orthop Relat Res. 2003 Jan;(406):205-13. doi: 10.1097/01.blo.0000030075.92399.11. Clin Orthop Relat Res. 2003. PMID: 12579020

6

Progressive osseous heteroplasia in the face of a child.

Faust RA, Shore EM, Stevens CE, Xu M, Shah S, Phillips CD, Kaplan FS. Faust RA, et al. Among authors: kaplan fs. Am J Med Genet A. 2003 Apr 1;118A(1):71-5. doi: 10.1002/ajmg.a.10170. Am J Med Genet A. 2003. PMID: 12605446

7

Bone morphogenetic protein-4 regulation in fibrodysplasia ossificans progressiva.

Olmsted EA, Kaplan FS, Shore EM. Olmsted EA, et al. Among authors: kaplan fs. Clin Orthop Relat Res. 2003 Mar;(408):331-43. doi: 10.1097/00003086-200303000-00044. Clin Orthop Relat Res. 2003. PMID: 12616078

8

Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.

Ahn J, Serrano de la Pena L, Shore EM, Kaplan FS. Ahn J, et al. Among authors: kaplan fs. J Bone Joint Surg Am. 2003 Apr;85(4):667-74. doi: 10.2106/00004623-200304000-00013. J Bone Joint Surg Am. 2003. PMID: 12672843

9

Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification?

Hegyi L, Gannon FH, Glaser DL, Shore EM, Kaplan FS, Shanahan CM. Hegyi L, et al. Among authors: kaplan fs. J Pathol. 2003 Sep;201(1):141-8. doi: 10.1002/path.1413. J Pathol. 2003. PMID: 12950027

10

In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification.

Glaser DL, Economides AN, Wang L, Liu X, Kimble RD, Fandl JP, Wilson JM, Stahl N, Kaplan FS, Shore EM. Glaser DL, et al. Among authors: kaplan fs. J Bone Joint Surg Am. 2003 Dec;85(12):2332-42. doi: 10.2106/00004623-200312000-00010. J Bone Joint Surg Am. 2003. PMID: 14668502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page